https://www.selleckchem.com/pr....oducts/Cediranib.htm
02) or LR controls (14%, p = 0.02). FSH levels were 38.4% higher in those with vasomotor symptoms compared with those without symptoms (p = 0.021). CONCLUSIONS Reproductive-aged cancer survivors have a higher prevalence of vasomotor symptoms and vaginal dryness than their similar-aged peers. IMPLICATIONS FOR CANCER SURVIVORS Providers should be attuned to the high prevalence of menopausal symptoms in cancer survivors.Calorie restriction without malnutrition (CR) is considered as the most effective nongenetic nor pharmacological interv
Like
Comment
Share
